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Background: Systemic hypertension is a prominent feature in humans with metabolic syndrome (MS) and this is
partly caused by an enhanced endothelin-1 (ET-1) mediated vasoconstriction. There are indications that systemic
hypertension might be a feature in equine metabolic syndrome (EMS) but if ET-1 is involved in the development of
hypertension in horses is not known. Increased levels of cortisol have also been found in humans with MS but
there are no reports of this in horses. Before blood pressure, plasma ET-1 and serum cortisol can be evaluated in
horses with EMS, it is necessary to investigate the interday variation of these parameters on clinically healthy horses.
The aims of the present study were therefore to evaluate the interday variation and influence of transportation on
systemic blood pressure, plasma ET-1 and serum cortisol in healthy Standardbred and Icelandic horses, and to
detect potential breed differences.
Methods: Nine horses of each breed were included in the study. Blood pressure was measured and blood samples
were collected between 6 and 9 am on two separate days. Eight of the horses (four of each breed) were
transported to a new stable were they stayed overnight. The next morning, the sampling procedure was repeated.
Results: The interday variation was higher for plasma ET-1 (37%) than for indirect pressure measurements (8-21%)
and serum cortisol (18%). There were no differences in systemic blood pressure between the two breeds. The
Icelandic horses had significantly lower serum cortisol and significantly higher plasma ET-1 concentrations
compared to the Standardbred horses. Plasma ET-1 was significantly elevated after transportation, but systemic
blood pressure and serum cortisol did not differ from the values obtained in the home environment.
Conclusions: Indirect blood pressure, plasma ET-1 and serum cortisol are of interest as markers for cardiovascular
dysfunction in horses with EMS. The elevated plasma ET-1 concentrations recorded after transportation was likely
caused by a stress response. This needs to be considered when evaluating plasma ET-1 in horses after
transportation. The differences detected in plasma ET-1 and serum cortisol between the two breeds might be
related to differences in genetic setup, training status as well as management conditions.
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Equine metabolic syndrome (EMS) was introduced in vet-
erinary medicine in 2002 and is a clinical condition char-
acterized by obesity, regional adiposity, insulin resistance
(IR) and clinical or subclinical laminitis [1,2]. A similar
syndrome exists in human medicine; the metabolic syn-
drome (MS), which is characterized by IR, abdominal
obesity, dyslipemia, coagulopathies, hyperglycemia and
systemic hypertension [3]. There are indications that sys-
temic hypertension might be a feature in EMS, as ponies
with EMS and a previous history laminitis have been
reported to have elevated systemic blood pressures during
summer [4]. The systemic hypertension seen in obese MS
patients with IR is partly due to a vascular endothelial dys-
function with a decreased production of the vasodilator
nitric oxide and an enhanced endothelin (ET-1) mediated
vasoconstriction [5-7]. If ET-1 is involved in the develop-
ment of the previously reported seasonal hypertension in
ponies is not known, as there are no studies that describe
plasma ET-1 levels in horses diagnosed with EMS.
In humans, the similarities between MS and Cushings´s
disease has raised the question if elevated cortisol levels
are associated with the development MS [8,9]. There are
studies that have shown that patients with MS have higher
circulating concentrations of cortisol, but there are also
studies that have failed to find this relationship [10,11]. To
our knowledge there are no studies that have measured
serum cortisol concentrations in horses diagnosed with
EMS, and the question remains whether horses with EMS
differ in cortisol concentration compared to controls. Cor-
tisol concentrations have a circadian rhythm in horses but
this rhythm is easily disturbed by factors such as transpor-
tation and changes in management and feeding [12,13].
The diagnostic test often used to detect horses suffering
from EMS is a combined glucose and insulin tolerance
test (CIGT-test) [2,14] and the test is usually performed in
a clinical setting. The stress response caused by the trans-
portation to the clinic and the change in environment has
the potential to affect not only cortisol concentrations, but
also the results of other markers for metabolic and cardio-
vascular changes used for diagnosing the disease. Before
blood pressure, plasma ET-1 and serum cortisol can be
evaluated in horses with EMS, it is therefore necessary to
investigate the interday variation of these parameters on
clinically healthy horses.
The aims of the present study were therefore to evaluate
the interday variation and influence of transportation on
systemic blood pressure, plasma ET-1 and serum cortisol
in healthy Standardbred and Icelandic horses, and to de-
tect potential breed differences. An additional aim was to
compare two different oscillometeric blood pressure
measurement devices, the Cardell Veterinary Vital Signs
Monitor (Cardell) and the Memo Diagnostic High Defin-
ition Oscillometry Monitor (HDO).Materials and methods
The study was sanctioned (C27/11) by the Ethical Com-
mittee for Animal Experiments, Uppsala, Sweden.
Horses
Nine Standardbred (7 mares and 2 geldings; body weight
425–586 kg; age 6–20 years) and nine Icelandic horses
(7 mares and 2 geldings, body weight 333–444 kg; age
10–18 years) were included in the study. The Standard-
bred horses were owned by the Department of Clinical
Sciences and kept in box stalls with a daily turn out in a
paddock. The horses were fed a standardized diet con-
sisting of hay (three times/day) and concentrate (once
daily) and provided water ad libitum. The Icelandic
horses were privately owned and mainly in free range in
a paddock but were also kept in box stalls on a regular
basis. These horses were fed grass haylage (three times/
day) and provided water ad libitum. All Standardbreds
were sedentary horses whereas eight of the Icelandic
horses performed lighter exercise three to five times a
week and one was sedentary. Four of the Standardbred
horses (three mares and one gelding; body weight 425–
586 kg; 6–19 years) and four of the Icelandic horses
(two mares and two geldings; body weight 326–412 kg;
10–18 years) were included in the transportation study.
None of the horses included in the study showed any
signs of disease on the clinical examination that was per-
formed before the start of the study.
Blood pressure measurement devices
Systolic, diastolic, and mean indirect arterial pressures
were obtained with Cardell (Cardell Veterinary Monitor
9402, CAS Medical Systems, Brandford, CT) and HDO
(Memo Diagnostic High Definition Oscillometry Moni-
tor, horse model) oscillometric monitors. For the trans-
portation study only the HDO device was used. For each
monitor, indirect blood pressure was obtained from cuffs
placed at the base of the tail (middle coccygeal artery)
according the manufacturer’s instructions. The cuff size
for the Cardell device was 11 cm and 8 cm for the HDO
device. Both devices automatically inflate an occluding
cuff and use the oscillometric measurement technique
for determination of systolic, diastolic, mean arterial
blood pressure and heart rate. The cuffs were reposi-
tioned as needed to acquire data acceptable to the in-
ternal sensor of the monitor. The same cuff size
accompanied each device through all measurements.
Experimental protocol
The blood pressure measurements and the sample col-
lection were performed between March and April 2011,
before the horses had access to summer pasture. The ar-
terial systemic blood pressure was measured between 6
and 9 am on two separate days (M1 and M2). The cuffs
Table 1 Interday variation in systemic blood pressure
(mmHg) and mean concentrations of plasma ET-1 (pg/ml)
and serum cortisol (mmol/l)
Variable M1 M2 CV %
HDO
BPS (mmHg) 114 ± 14 113 ± 18 15
BPD (mmHg) 71 ± 11 67 ± 15 21
Cardell
BPS (mmHg) 104 ± 12 102 ± 10 8
BPD (mmHg) 65 ± 13 60 ± 10 19
ET-1 (pg/ml) 2.3 ± 1.4 2.7 ± 2.0 37
Cortisol (nmol/l) 129 ± 76 126 ± 81 18
Mean (±SD) values for systemic, systolic and diastolic blood pressure
(measured with the HDO and the Cardell device), plasma ET-1 and serum
cortisol concentration measured on two separate days (M1 and M2). No
significant differences between M1 and M2 were detected for any of the
variables. (P≤ 0.05) BPS: systolic blood pressure, BPD: diastolic blood pressure,
CV: Coefficient of variation. n = 18, except for plasma ET-1 where n = 16.
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horse was standing in the box stall. Five consecutive
determinations of systolic and diastolic blood pressure
were performed on each horse, using both devices. On
the first day of the study, the starting order in which of
the two blood pressure measurement devices were used
was randomized by raffle. The next day the starting
orders of the devices were switched. In each horse, blood
samples were drawn immediately after both blood pres-
sure measurements had been completed.
Transportation study
The horses were transported in a two-horse trailer for
one hour to a new stable were they stayed overnight.
The next morning, the blood pressure was measured
(HDO) and blood samples collected (M3) in the same
manner as previously described.
Sampling
Blood samples for analysis of plasma ET-1 and serum
cortisol were drawn using vacutainer technique and col-
lected in evacuated NaEDTA and serum glass tubes
(Vacutainer, BD, Belliver Industrial Estate, Plymouth,
UK). In each horse, the blood samples were drawn im-
mediately after the blood pressure measurements had
been completed. All samples were kept on ice until cen-
trifuged for 10 min (+4°C, 2700 g), plasma and serum
subsequently harvested and stored in a −80°C freezer
until analysis.
Sample analysis
Plasma ET-1 concentrations were measured in duplicate
with a commercial ELISA-kit (Endothelin (1–21) enzyme
immunoassay, Biomedica Medizinprodukte GmbH & Co
KG, Wien, Austria). Serum cortisol concentrations (hydro-
cortisone Compound F) were measured in duplicates with
a radioimmunoassay-kit (Coat-A-CountW Cortisol, TKCO2,
SIEMENS, USA).
Statistical methods
In each horse, the lowest and highest recorded value of
the five consecutive blood pressure determinations were
excluded and the mean systolic and diastolic pressure
was calculated from the three remaining determinations
(triplicates). The statistical analysis was performed using
SigmaPlot software version 11 (SigmaPlot software ver-
sion 11, SPSS Science, USA).
The results of repeated tests for indirect blood pressure
measurement, plasma ET-1 and serum cortisol were com-
pared by use of a paired t-test (M1 and M2) or one way
repeated measures analyses of variance (M1, M2, and M3;
transportation study). Differences between individual
means for the three days were tested with a tukey test. Dif-
ferences in the two breeds for measurement of indirectblood pressure measurement, plasma ET-1 and serum cor-
tisol were compared by use of a t-test whereas differences
between the blood pressure measurement devices were
compared by use of a paired t-test. Measurement error,
defined as the variation between measurement of the same
quantity on the same animal, blood pressure device and
ELISA- and radioimmunoassay-kit, was expressed as the
coefficient of variation (CV). The standard deviation for du-
plicate or triplicate measurements was calculated according
to Bland [15]. The CV was calculated as the SD divided by
the means of each set of two or three measurements and
expressed in percentage. Values are expressed as mean±
SD. The level of significance was set at (P≤ 0.05).
Results
Systolic and diastolic indirect blood pressure
measurements
The mean systolic blood pressure differed significantly be-
tween the two devices (HDO, 114±14 mmHg; Cardell,
104±12 mmHg), but not the mean diastolic blood pressure
(HDO, 71±11 mmHg; Cardell, 65±13 mmHg) (Table 1).
The CV for three repeated measurements on the same oc-
casion were 5.4% in systole and 13.9% in diastole for the
Cardell device and 9.5% in systole and 12.1% in diastole for
the HDO device. The Cardell showed a better inter-assay
CV in systole than the HDO, but there was no difference
between the two devices in diastole. Regardless of which
blood pressure measurement device that was used, there
was no difference in mean systolic or diastolic blood pres-
sure between M1 and M2 (Table 1) or between the two
breeds.
Plasma ET-1 and serum cortisol
One Icelandic horse had plasma ET-1 concentrations
that were considered as unreasonably high (16.41 and
Table 3 The effect of transportation and new
environment on systemic blood pressure (mmHg) and
mean concentrations of plasma ET-1 (pg/ml) and serum
cortisol (mmol/l)
Variable M1 M2 M3 CV %
HDO
BPS (mmHg) 114 ± 6 110 ± 11 119 ± 10 6
BPD (mmHg) 71 ± 6 67± 9 75± 7 9
ET-1 (pg/ml) 1.7 ± 0.9 1.7 ± 0.9 2.6 ± 1.2* 31
Cortisol (nmol/l) 113 ± 60 115 ± 74 122 ± 35 33
Mean (±SD) values for systemic, systolic and diastolic blood pressure
(measured with the HDO), plasma ET-1 and serum cortisol concentration
measured on two separate days (M1 and M2) and after transportation (M3).
*P< 0.05 versus MI and M2. BPS: systolic blood pressure, BPD: diastolic blood
pressure, CV: coefficient of variation. n = 8, except for plasma ET-1 where n = 7.
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variation in plasma ET-1 concentrations between mea-
surements (3.09 and 14.54 pg/ml). These values were
therefore excluded from the calculations of plasma ET-1.
One of these horses took part in the transportation
study, and the ET-1 values of this horse were excluded
since it had concentrations above the detection limit.
There was no significant difference between M1 and M2
in the mean concentration of plasma ET-1 and serum
cortisol (Table 1). The intra-assay CV for plasma ET-1
was 6.7% and the intra-assay CV for serum cortisol was
5.7%. Mean concentrations of plasma ET-1 and serum
cortisol both differed significantly between the two
breeds with the Icelandic horses having significantly
higher plasma ET-1 concentrations and significantly
lower serum cortisol concentrations compared to the
Standardbred horses (Table 2).
Influence of transportation
The transportation and new environment did not affect
the mean systolic or diastolic blood pressure or mean
serum cortisol concentration (Table 3). The mean plasma
ET-1 concentration was significantly higher when mea-
sured after transportation compared to the home environ-
ment (Table 3).
Discussion
The results of the present study showed that the interday
variation differed between the studied parameters with
plasma ET-1 showing the greatest interday variation. The
wide range in interday variation is to be expected as simi-
lar interday fluctuations have been reported for other hor-
mones and physiological parameters [16,17]. The
concentrations of plasma ET-1 measured in the present
study was higher for both breeds compared to theTable 2 Systolic and diastolic blood pressure (mmHg) and
mean concentrations of plasma ET-1 (pg/ml) and serum
cortisol (mmol/l) in Standardbred and Icelandic horses
Variable Standardbred horses Icelandic horses
HDO
BPS (mmHg) 118 ± 17 110 ± 11
BPD (mmHg) 74 ± 11 67 ± 11
Cardell
BPS (mmHg) 103± 9 105 ± 14
BPD (mmHg) 64 ± 7 66± 17
ET-1 (pg/ml) 1.5 ± 0.5 3.2 ± 1.7*
Cortisol (nmol/l) 188 ± 63 70 ± 22*
Mean (±SD) values for systemic, systolic and diastolic blood pressure
(measured with the HDO and the Cardell device), plasma ET-1 and serum
cortisol concentration measured in two different breeds (Standardbred horses
and Icelandic horses). * P< 0.05 versus Standardbred horses. BPS: systolic
blood pressure, BPD: diastolic blood pressure. n = 9, except for plasma ET-1 in
the Icelandic horses where n = 7.concentrations reported previously in healthy Thorough-
bred and Standardbred horses [18] but similar to those
reported in horses with summer pasture associated recur-
rent airway obstruction, SPA-RAO [19] and horses with
clinical endotoxaemia [20]. The discrepancy in results be-
tween studies are likely related to the use of different
ELISA assays [19,20], all developed for quantification of
human ET-1, as well as genetic differences between
breeds. The assay used in the present study had a cross-
reactivity with equine ET-1 of a 100%. It is therefore pos-
sibly that assays with lower cross-reactivity might under-
estimate endothelin concentrations.
An interesting finding was the difference in plasma ET-
1 and serum cortisol concentrations between the two
breeds. The results of the present study showed that the
Icelandic horses had significantly higher plasma ET-1 con-
centrations than the Standardbred horses. There was a
considerable individual variation in the concentrations of
plasma ET-1 in both breeds, which is in agreement with
previous studies in both healthy horses and horses
affected of SPA-RAO [19]. However, the individual vari-
ation was greater in the Icelandic horses. The reason for
this difference between breeds is not known, but might be
related to both genetic differences as well differences in
management. Previous studies in ponies and Icelandic
horses have reported that they are partially insulin resist-
ant compared to normal horses [21-23]. Insulin is known
to stimulate the production of nitric oxide as well as the
production of ET-1 in endothelial cells [24-26]. In the
healthy state there is a balance between the insulin stimu-
lated release of NO and ET-1 from the endothelium. In
individuals with IR or hyperinsulinemia the production of
nitric oxide is decreased but the stimulatory effect of insu-
lin in ET-1 is preserved leading to vasoconstriction and
hypertension [27]. This could also explain the higher ET-1
values seen in the Icelandic horses compared to the Stand-
ardbred horses, as elevated insulin levels could cause an
increase in ET-1 concentration [28]. The higher plasma
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study did not cause an elevation of the systemic blood
pressure.
In horses, cortisol production has a circadian rhythm
with peak levels in the early morning and a nadir at
night [12,29]. Because of the circadian rhythm sampling
results are also influenced by sampling time [12]. Inves-
tigation of cortisol in untrained Standardbred horses in
their home environment showed a circadian rhythm
with a peak between 6 and 9 am [12]. These results sug-
gest that the horses in the present study were sampled
at the time of peak cortisol concentration. The circadian
rhythm can easily be abolished by any disturbances like
fasting and removal from the accustomed environment
[12,13]. The Icelandic horses in the present study had
significantly lower concentrations of plasma cortisol
than the Standardbred horses. The concentrations mea-
sured in the Icelandic horses, are similar to the concen-
trations measured in Icelandic horses in an earlier study
[30]. In that study, no differences in the concentrations
of serum cortisol could be detected between Standard-
bred and Icelandic horses feed the same diet [30]. Our
groups of horses were not feed the same diet, but previ-
ous research have failed to show any impact of different
diets on cortisol concentrations in horses [29]. The
mean concentration of cortisol of the sedentary Stand-
ardbred horses in the present study is in good agreement
with the mean concentration previously reported in well
trained cross-bred trekking horses indicating that the
differences in cortisol concentrations was influenced by
other factors than fitness status [31]. Chronic inflamma-
tion is known to depress cortisol concentrations in
horses [32] and systemic inflammation is an important
component of EMS [33]. The lower mean cortisol con-
centrations shown in the Icelandic horses in the present
study could be related to breed differences, partial IR or
be management dependent.
After transportation and exposure to a new environment,
plasma ET-1 concentrations differed significantly from the
concentrations measured in the home environment. This is
likely related to a stress reaction caused by the transporta-
tion and the new environment. No significant differences
were detected in the cortisol concentrations measured after
transportation compared to the measurements in the home
environment. This is in contrast to findings from a previous
study, were higher serum cortisol levels were found in
horses that had been transported compared to a group of
non-transported horses [31]. The reason for this discrep-
ancy in results between studies could be related to differ-
ences in sampling time. The horses in the present study
spent a minimum of 12 hours in the new box stalls before
the sample collection took place which might have been
long enough for the pulsatile secretion of cortisol to rees-
tablish [13,34]. In the study by Medica et al. (2010), thesample collection was carried out the same day as the
transportation occurred and the time interval between
transportation and sampling might have been too short for
a reestablishment of the pulsatile secretion. The results of
the present study indicate that serum cortisol and indirect
blood pressure can be measured with reliable results if sam-
ples are collected at least 12 hours post-transportation. This
is supported from findings from a study in donkeys were
transportation altered the normal rhythm of resting cortisol
to an increased rate of continuous secretion in both fed
and fasted animals with a reestablishment of the circadian
rhythm 8.5-10.5 hours later [13].
The significant difference in the concentrations of ET-
1 and cortisol between the two breeds was not reflected
in any differences in blood pressure. Previous studies
have found that laminitis prone ponies have a different
metabolic profile compared to non-laminitic ponies with
significantly higher BCS, plasma insulin concentrations
as well as decreased cortisol concentrations [4,35]. The
metabolic profile and the predisposition for laminitis
also seem to be inherited [35]. It is possible that the dif-
ferences reported in plasma ET-1 and serum cortisol be-
tween breeds also are inherited and part of a metabolic
profile associated with EMS. However, this must be fur-
ther investigated on a larger material of horses of differ-
ent breeds.
Both blood pressure measurement devices gave values
that showed an acceptable interday variation. The indirect
oscillometric blood pressure technique is known to over-
estimate the systolic blood pressure in dogs compared to
the direct blood pressure technique [23-37]. However, if
the clinician is aware of the possible risk that indirect
blood pressure measurement techniques might overesti-
mate the blood pressure, the risk of falsely diagnosing
hypertension in horses appears to be little. In the present
study, the HDO device gave higher values in systole com-
pared to the Cardell device. This could partly be related to
the difference in cuff size between the two devices. The
size of the cuff is known to influence the obtained blood
pressure values where a cuff that is too wide underesti-
mates the blood pressure whereas a cuff that is too narrow
tends to overestimate the values. The optimum cuff width
for horses is one-fifth of the tail circumference [38]. It is
therefore important that the cuff used is adjusted for each
type of horse and the greater cuff size of the Cardell might
be preferable in horses with a wide tail, such as some of
the Icelandic horses in the present study. However, the
results from the present study indicate that both devices
can be used to measure systemic blood pressure in Stand-
ardbred as well as Icelandic horses. There are results that
indicate that the HDO device has a better correlation with
the direct blood pressure measurement technique com-
pared to the Cardell device [39]. A previous study in dogs
also showed that although the blood pressure values
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than the values obtained with the direct blood pressure
measurement technique, there was a good correlation be-
tween the two techniques [37]. Both devices can be run
on battery, which makes it possible to use them during
field conditions. The results from this study showed that
the Cardell device had less interday variation in systole
compared to the HDO device. However, the Cardell is
large and impractical to handle in a field setting whereas
the HDO device is smaller in size, lighter and easier to
handle. The previously reported high sensitivity and good
correlation with the direct blood pressure measurement
technique for the HDO device is also advantageous.
Conclusions
In conclusion, indirect blood pressure measurements,
plasma ET-1 and serum cortisol all showed an acceptable
interday variation and are candidates for further investiga-
tion in horses with Equine metabolic syndrome. Both the
Cardell and the HDO device can be used for measurement
of indirect blood pressure in horses, but the HDO was most
practical to handle, especially in a field setting. There seem
to exist a breed difference in the concentrations of plasma
ET-1 and serum cortisol. Transportation and housing in a
new environment seemed to influence the concentrations
of plasma ET-1 but not serum cortisol. All of these factors
need to be considered when indirect blood pressure,
plasma ET-1 and serum cortisol are used in a clinical set-
ting. Future studies that investigate the possible seasonal
variation in blood pressure, ET-1 and cortisol on healthy
horses of different breeds and of horses clinically affected of
EMS are desirable.
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